Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-25-014771
Filing Date
2025-02-18
Accepted
2025-02-18 16:15:16
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 5612
  Complete submission text file 0001104659-25-014771.txt   7128
Mailing Address 2609 CALDWELL MILL LN BIRMINGHAM AL 35243
Business Address
SATTERFIELD THOMAS A JR (Filed by) CIK: 0001132317 (see all company filings)

Type: SCHEDULE 13G/A

Mailing Address 100 SPY COURT MARKHAM A6 L3R 5H6
Business Address 100 SPY COURT MARKHAM A6 L3R 5H6 (905) 475-1234
Edesa Biotech, Inc. (Subject) CIK: 0001540159 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0930
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-87615 | Film No.: 25635066
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)